Interleukin (IL)‐6 and receptor activator of nuclear factor (NF)‐κB ligand (RANKL) are increased in the serum of a patient with primary pachydermoperiostosis

D. Rendina Department of Clinical and Experimental Medicine, ‘Federico II’ University Medical School, Naples

G. De Filippo Paediatric Endocrinology Unit, A.O.R.N. ‘G. Rummo’, BeneventoCorrespondence[email protected]

R. Viceconti Department of Clinical and Experimental Medicine, ‘Federico II’ University Medical School, Naples

E. Soscia Department of Biomorphological and Functional Science – Department of Diagnostic Imaging and Radiotherapy, ‘Federico II’ University Medical School, Naples

C. Sirignano National Research Council (CNR) Biostructures and Bioimaging Institute, ‘Federico II’ University Medical School, Naples

M. Salvatore Department of Biomorphological and Functional Science – Department of Diagnostic Imaging and Radiotherapy, ‘Federico II’ University Medical School, Naples

M. Della Monica Medical Genetics Unit, A.O.R.N. ‘G. Rummo’, Benevento, Italy

G. Scarano Medical Genetics Unit, A.O.R.N. ‘G. Rummo’, Benevento, Italy

G. Mossetti Department of Clinical and Experimental Medicine, ‘Federico II’ University Medical School, Naples

show all

Interleukin (IL)‐6 and receptor activator of nuclear factor (NF)‐κB ligand (RANKL) are increased in the serum of a patient with primary pachydermoperiostosis

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Interleukin (IL)‐6 and receptor activator of nuclear factor (NF)‐κB ligand (RANKL) are increased in the serum of a patient with primary pachydermoperiostosis

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date